Cargando…

Comprehensive role of prostate‐specific antigen identified with proteomic analysis in prostate cancer

Current treatments including androgen deprivation fail to prevent prostate cancer (PrCa) from progressing to castration‐resistant PrCa (CRPC). Accumulating evidence highlights the relevance of prostate‐specific antigen (PSA) in the development and progression of PrCa. The underlying mechanism whereb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Haoyong, Ma, Zhe, Che, Zhifei, Li, Qi, Fan, Jinfeng, Zhou, Zhiyan, Wu, Yaoxi, Jin, Yingxia, Liang, Peiyu, Che, Xianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520270/ https://www.ncbi.nlm.nih.gov/pubmed/33107155 http://dx.doi.org/10.1111/jcmm.15634

Ejemplares similares

AID modulates carcinogenesis network via DNA demethylation in bladder urothelial cell carcinoma
por: Li, Haoyong, et al.
Publicado: (2019)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Prostate specific antigen /
Publicado: (2001)

Age-specific percentile-based prostate-specific antigen cutoff values predict the risk of prostate cancer: A single hospital observation
por: Hsieh, Teng-Fu, et al.
Publicado: (2023)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Association of Diet With Prostate Specific Antigen and Prostate Volume
por: Shirazi, Mehdi, et al.
Publicado: (2014)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
por: Shahab, Ahmad Anies, et al.
Publicado: (2013)

Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
por: Yang, Teng-Kai, et al.
Publicado: (2019)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Advice About Screening for Prostate Cancer With Prostate-Specific Antigen
por: Jean-Pierre, Gannel
Publicado: (2017)

Re: Prognosis of prostate cancer and prostate - specific antigen levels
por: Joob, Beuy, et al.
Publicado: (2019)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer
por: Zhang, Qingxu, et al.
Publicado: (2023)

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer
por: Hoffmann, Thomas J., et al.
Publicado: (2017)

Phage display screening identifies a prostate specific antigen (PSA)(–/lo) prostate cancer cell specific peptide to retard castration resistance of prostate cancer
por: Sui, Yi, et al.
Publicado: (2021)

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population
por: Ganpule, Arvind P., et al.
Publicado: (2007)

Effect of Heamolysis on Prostate-Specific Antigen
por: Sağlam, Hasan S., et al.
Publicado: (2012)

Comment on the discovery of prostate specific antigen
por: Lue, Tom F.
Publicado: (2014)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

Biocompatibility and efficacy of prostatic urethral lift in benign prostate hyperplasia: an in vivo and in vitro study
por: Xia, Yuqi, et al.
Publicado: (2023)

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in (11)C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence
por: Dusing, Reginald W., et al.
Publicado: (2014)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity
por: Nitta, Satoshi, et al.
Publicado: (2019)

Prostate specific antigen for early detection of prostate cancer: longitudinal study
por: Holmström, Benny, et al.
Publicado: (2009)

Bioimpedance and chronoamperometry as an adjunct to prostate-specific antigen screening for prostate cancer
por: de Abreu, Darci Schiavon
Publicado: (2011)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

Prostate specific antigen change after administration of nimotuzumab in prostate cancer
por: Chaiyasit, Kamon, et al.
Publicado: (2013)

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
por: Vickers, Andrew J, et al.
Publicado: (2014)

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
por: Cho, Hee Ju, et al.
Publicado: (2014)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
por: Cabarkapa, Sonja, et al.
Publicado: (2016)

Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
por: Nyame, Yaw A, et al.
Publicado: (2020)

Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
por: Narain, Tushar Aditya, et al.
Publicado: (2022)

Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
por: Yang, Cheng-Kuang, et al.
Publicado: (2023)

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
por: Määttänen, L, et al.
Publicado: (2007)

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
por: Gilbert, Rebecca, et al.
Publicado: (2018)

Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
por: Lee, Sang Hun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9uca6odm3t0od611t5mtln54g0